Month: March 2026

SUNGAI PENTANI, Malaysia, March 23, 2026 (GLOBE NEWSWIRE) — Linkers Industries Limited (NASDAQ: LNKS) (the “Company”), a manufacturer and supplier of wire and cable harnesses with operations in Malaysia, today announced the pricing of a best efforts public offering with gross proceeds to the Company of approximately $16 million, before deducting placement agent fees and other estimated expenses payable by the Company. The offering is comprised of 23,088,023 units consisting of one of the Company’s Class A ordinary shares (“Ordinary Shares”) (or a pre-funded warrant to purchase one Ordinary Share in lieu thereof), one Series A Warrant to purchase one Ordinary Share at an initial exercise price of $0.7277 per share (the “Series A Warrants”) and one Series B Warrant to purchase one Ordinary Share at an initial exercise price of $1.1781...

MIAMI, March 23, 2026 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or, the “Company”), a global leader in non-lethal response and public safety technology, today announced it will hold a conference call on Thursday, March 26, 2026 at 4:15 p.m. Eastern Time (1:15 p.m. Pacific Time) to discuss its financial and operational results for the fourth quarter and full year ended December 31, 2025. Wrap management will host the presentation, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call at ir@wrap.com by 5:00 p.m. Eastern Time on March 25, 2026. Questions will be addressed based on the relevance to the Company’s strategic direction and execution, stockholder base and public disclosure rules. Date: Thursday, March 26, 2026Time: 4:15 p.m. Eastern Time...

As enterprises and neo-clouds invest billions in private AI infrastructure, Check Point delivers the industry’s most comprehensive security architecture for AI data centers REDWOOD CITY, Calif., March 23, 2026 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a pioneer and global leader of cyber security solutions, today released the AI Factory Security Architecture Blueprint — a comprehensive, vendor-tested reference architecture for securing private AI infrastructure from the hardware layer to the application layer. Leveraging Check Point’s industry-leading firewall and AI security technologies, and building on NVIDIA BlueField data processing capabilities, the blueprint delivers security-by-design across every layer of the AI factory and data center. “AI infrastructure has become one...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 23, 2026 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today published the invitation to the Annual General Meeting 2026 and announced the nomination of Clare Fisher for election as a new member of the Board of Directors (BoD) at the Annual General Meeting. The Annual General Meeting will be held on Tuesday, April 14, 2026, 9:00 am CET (doors open at 8:30 am CET), at JED Events, Zürcherstrasse 39, 8952 Schlieren, Switzerland. Invitation to the Annual General Meeting 2026 with the corresponding agenda items. Einladung zur Generalversammlung 2026 mit den zugehörigen Traktandenpunkten. “We are pleased...

MELBOURNE, Australia, March 23, 2026 (GLOBE NEWSWIRE) — Cortexa (Cortexa or the Company), a leading psychedelic medicines supplier, reaffirms its market leading position in FY2026 for MDMA (3,4-methylenedioxymethamphetamine). Cortexa is a 50/50 joint venture between PharmAla Biotech (CSE: MDMA) and Vitura Health (ASX: VIT). Following completion of the world’s largest (and first Australian) GMP batch of MDMA capsules earlier this financial year, the Company has secured supply arrangements with authorised providers nationally to support clinical programs and patient treatment under Australia’s regulated prescribing pathways. Through Cortexa market activities, the majority of the initial batch has now been committed. The Cortexa sales value for these activities will exceed AUD$1.0 Million. To support current and future requirements,...

TAIZHOU, China, March 23, 2026 (GLOBE NEWSWIRE) — China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”),  a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced that upon the market opening on March 24, 2026, the Company’s Class A Ordinary Shares will be traded on The Nasdaq Stock Market under the symbol “SXTC”. On July 28, 2025, the Company held a special meeting of shareholders (the “Meeting”). At the Meeting, shareholders approved a change to the Company’s authorized share capital to establish a dual class share structure by (i) creating a new class...

SOUTH SAN FRANCISCO, Calif., March 23, 2026 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced upcoming presentations featuring clinical and translational data from its SENTI-202 program at the 11th Annual Innate Killer Conference, taking place March 24–25, 2026 in San Diego, California. The presentations will include data from the ongoing Phase I clinical trial of SENTI-202, a first-in-class, off-the-shelf, logic-gated CAR NK cell therapy designed to selectively target CD33 and/or FLT3 while sparing EMCN-expressing healthy cells in adults with relapsed/refractory acute myeloid leukemia (AML). The presentations details are as follows: Clinical Data PresentationRochelle...